Company intelligence / Profile preview

Quantum Surgical

Montpellier, Occitanie, Francequantumsurgical.com ↗

Ownership: Private
Employees: ~130
Development stage: Commercial

Overview

The Epione® robotic platform enables minimally invasive percutaneous tumor ablations. It has treated over 800 patients worldwide and is used in at least fifteen cancer centers across Europe and the USA. Clinical adoption continues to expand with recent partnerships in Asia. The company was awarded the Prix Galien USA in 2022 for its innovation.

Therapeutic areas: Oncology
Modalities: Device (robotic-assisted ablation platform)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Epione

Commercial

Indications: Abdominal cancer, Lung cancer

Partnerships

Unison Healthcare Group/UHG (Taiwan distribution partner)

Beyond the preview

Go deeper on Quantum Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quantum Surgical.

Explore the full profile